Advertisement

You will be redirected to the page you want to view in  seconds.

MedCity News

MedCity News » Northeast Ohio

  • MedCity News

Dr. Oz and Michael Roizen health coaching startup raises $1.6 million

May 18, 2012

A health coaching startup founded by Cleveland Clinic wellness chief Dr. Michael Roizen and TV star Dr. Mehmet Oz has raised $1.6 million, according to a regulatory document. MedCity News reported in March that Enforcer eCoaching was aiming to raise $3 million in investment funding. A subsequent regulatory filing revealed that the company has raised $1.6 [...]

  • MedCity News

Cleveland Clinic to help Notre Dame commercialize medical innovations

May 18, 2012

Following on the heels of two hospitals, the University of Notre Dame has become the first university to strike a collaboration with Cleveland Clinic aimed at commercializing medical innovations from its faculty and researchers. Through the collaboration, Cleveland Clinic Innovations will essentially do for Notre Dame what it does for the Clinic — help turn employee [...]

  • MedCity News

Protecting your IP: Q&A with a patent attorney about China and the AIA

May 17, 2012

Patent laws are changing. The America Invents Act has shifted U.S. patent laws to a “first-to-file” system from a “first-to-invent” system, according to attorney Steven Auvil, chair of the intellectual property practice group at Benesch in Cleveland. Auvil’s work focuses largely on litigation of intellectual property disputes. In the interview below, he discusses changes to patent laws that [...]

  • MedCity News

New partnership could boost CoverMyMeds’ health insurance customer base

May 17, 2012

A new partnership with a company that bills itself as having the most broad-reaching healthcare communication network in the country could increase health IT startup CoverMyMeds‘ health insurance customer base. Cleveland-area CoverMyMeds (CMM) has developed Web-based tools that speed up and automate the submission of prior authorization requests to health insurance plans. Insurers sometimes require these [...]

  • MedCity News

Is crowdfunding good or bad for angel investors?

May 16, 2012

In the world of startups, few separate topics of discussion have recently been hotter than angel investing and crowdfunding. But what about considering where crowdfunding and angel investing intersect? Can these two forms of startup fundraising co-exist peacefully or might crowdfunding pose a threat to angel investors? In short, it’s too early to say, but angels shouldn’t [...]

  • MedCity News

AxioMed gets CE Mark for cervical spinal disc replacement device

May 15, 2012

Medical device developer AxioMed Spine has received European regulatory approval to market its cervical spinal disc replacement device. The CE Mark for AxioMed’s Freedom cervical disc complements the earlier European regulatory approval for the company’s Freedom lumbar spinal disc replacement, according to a statement from the Cleveland-area company. AxioMed is currently selling the lumbar disc in three [...]

  • MedCity News

Regenerative medicine company begins enrollment in critical limb ischemia trial

May 15, 2012

Regenerative medicine startup Juventas Therapeutics has begun enrollment in a phase 2a trial of critical limb ischemia patients. The Cleveland-based company, which recently secured an important investment from Takeda Pharmaceuticals, is planning to enroll 48 patients and complete enrollment early next year, CEO Rahul Aras said. Juventas’ technology, called JVS-100, works by recruiting stem cells from the [...]

  • MedCity News

Everything you know about entrepreneurship is wrong

May 15, 2012

Scott Shane seems to delight in sharing harsh realities about entrepreneurship and economic development. Shane, a Case Western Reserve University economics professor who authors a regular column for Business Week, castigates a culture that promotes a “naive view of entrepreneurship and starting businesses” in his 2008 book “The Illusions of Entrepreneurship: The Costly Myths That Entrepreneurs, [...]

  • MedCity News

Athersys-Pfizer IBD phase 2 trial to wrap up by end of the year

May 14, 2012

Stem cell therapeutics developer Athersys’ (NASDAQ:ATHX) phase 2 clinical study investigating the treatment of inflammatory bowel disease with partner Pfizer (NYSE:PFE) is expected to complete patient enrollment by the end of 2012. Top-line results of the inflammatory bowel disease trial are likely to be available in early 2013, Athersys CEO Gil Van Bokkelen said in a [...]

  • MedCity News

Cleveland HeartLab at TEDMED (video)

May 14, 2012

Biomarker test company Cleveland HeartLab made a splash recently at TEDMED, with about 500 conference-goers taking the company’s heart inflammation tests. Results of the TEDMED tests showed that 41 percent of those who submitted samples had high cholesterol or low HDL (good cholesterol), 28 percent showed evidence of hardening of the arteries and 12 percent tested [...]

  • MedCity News

Cleveland Clinic’s Health Hub aims to be go-to source for trusted health info

May 14, 2012

What’s your trusted source for health information on the Internet? Cleveland Clinic hopes the answer more and more people come up with to that question is “Health Hub.” The renowned hospital launched the Health Hub site at the end of March “with little fanfare,” but still drew 16,000 visits in April without promotion. The Clinic hopes the [...]

  • MedCity News

Therapeutic hypothermia device startup changes name to Cryothermic Systems

May 14, 2012

Therapeutic hypothermia medical device maker Life Core Technologies, which makes an emergency brain-cooling device, has a new name: Cryothermic Systems. Employing the term “cryo” in the Cleveland-area company’s brand better aligns its name with the company’s products and “will accurately reflect the company’s vision for future growth within its market,” according to a statement from Cryothermic [...]

  • MedCity News

Takeda to invest in regenerative medicine startup Juventas’ next round

May 11, 2012

Takeda Pharmaceuticals is a strategic investor in regenerative medicine company Juventas Therapeutics’ upcoming series B round of funding. Juventas’ CEO Rahul Aras discussed the investment during a panel at a meeting of the Ohio Venture Association on Friday. “If you think venture capital due diligence is difficult …” Aras joked, “I think [Takeda] called my mother.” Aras didn’t [...]

  • MedCity News

New site aims to become online destination for Indian doctors

May 10, 2012

A recently launched website called mdCurrent India is hoping to become a top online destination for Indian physicians. A former executive with publishing company Advanstar is behind the site, which looks to be somewhat analogous to an Indian version of two Advanstar properties aimed at U.S. physicians and health providers — Medical Economics magazine and ModernMedicine.com. “mdCurrent [...]

  • MedCity News

STERIS sees new fiscal year as ‘turning point’ as it completes System 1 transition

May 8, 2012

Medical device company STERIS (NYSE:STE) is viewing its recently started fiscal 2013 as a “turning point” for the company, as it moves beyond a lengthy and costly transition from its flagship sterilization system. Mentor, Ohio-based STERIS experienced several challenges to its bottom line last year, including costs associated with moving customers to its System 1E, a [...]

  • MedCity News

Are things finally looking up for the Cleveland medical mart?

May 7, 2012

Cleveland-area taxpayers can be forgiven if they’re a little skeptical about the outlook for the medical mart project they’ve been funding. For starters, the medical mart concept (a collection of product showrooms that feature the latest in medical technology) is unproven, and it’s never really been clear that the biggest players in the market are interested. Plus, [...]

  • MedCity News

Nashville medical mart project bounces back with new tenants, financing plans

May 4, 2012

After being left for dead more than once, Nashville’s medical mart project is showing surprising resilience and signifying that it isn’t time to bring out the coffin just yet. The Nashville Medical Trade Center on Friday announced six new tenants for the project, its first such announcement since August. Perhaps more importantly, the property developer behind [...]

  • MedCity News

Who better than high school seniors to solve the freshman 15?

May 3, 2012

A university-sponsored, incentive-driven wellness program for college students who want to avoid gaining the freshman 15. A smart inhaler that makes it easier for patients to monitor their asthma attacks. An all-in-one home-care assistance package for seniors. These ideas came from seniors at a Cleveland-area high school who are participating in their school’s business plan competition. [...]

  • MedCity News

Biobank aims to collect stem cells and tissues for use in future bone grafts

April 27, 2012

A startup has set out to create a biobank of stem cell-rich tissues collected during surgery with the idea that customers can use their own stored biomaterials for use in future bone graft procedures and stem cell therapies. Cleveland-based CellBank Technologies is modeling parts of its business on the cord blood bank industry, but instead of [...]

  • MedCity News

Pharmacist forgiven: Documentary featuring Jerry-Cropp meeting to air tomorrow on Discovery

April 27, 2012

A documentary that features the first meeting of a man whose daughter was killed by a medication error and the pharmacist who went to jail for it is scheduled to air tomorrow on the Discovery Channel. “Surfing the Healthcare Tsunami: Bring Your Best Board” includes an interview with Chris Jerry and Eric Cropp, two Cleveland-area men [...]

  • MedCity News

Regulatory, compliance issues continue to weigh down Invacare

April 26, 2012

Regulatory and compliance issues have diverted resources at home health products supplier Invacare (NYSE:IVC) away from “critical priorities” in the company’s business and have resulted in delays of new product introductions and slowed progress on a key globalization initiative. Those issues stem from negotiations with the U.S. Food and Drug Administration over a possible shutdown of [...]

  • MedCity News

Healthcare accelerators: Good for startups, not so good for VCs?

April 25, 2012

Panelists at a venture capital forum enthusiastically endorsed accelerators as providing plenty of value for entrepreneurs – mentorship, networking, business connections and the like.But several VCs on the panel were less confident about what sort of benefit, if any, accelerators could offer them. Joe Cunningham, a managing director with Austin, Texas-based...

  • MedCity News

Thermalin Diabetes gets $4.5M NIH grant for next-generation insulin

April 25, 2012

Next-generation insulin developer Thermalin Diabetes has received a $4.5 million grant from the National Institutes of Health to continue development of its insulin analogs. The grant is expected to fund Cleveland-based Thermalin through the filing of an investigational new drug (IND) application for a rapid-acting insulin analog drug candidate, CEO Rick Berenson said. “We are very excited [...]

  • MedCity News

New CWRU tech transfer chief looks to boost corporate partnerships

April 25, 2012

Bob Miller quietly began his post as Case Western Reserve University‘s top technology transfer official last October, but he’s likely to be much more vocal in seeking out corporate partnerships to help commercialize research coming out of the university. Miller, a professor in Case’s department of neuroscience, succeeded Case’s former tech transfer chief Mark Coticchia in [...]

  • MedCity News

How one children’s hospital cut surgical site infections by 60 percent

April 24, 2012

Surgical site infections are a nasty and persistent problem throughout the U.S. healthcare system, and affect as many as 5 percent of patients who undergo surgery. And with the rise of “superbugs,” or drug-resistant infections, the problem doesn’t appear to be going away any time soon. The cost to the U.S. health system of each surgical [...]